Objective: To evaluate agreement between 3 methods for screening anal intraepithelial lesions: anal cytology, anoscopy and human papillomavirus (HPV) detection by PCR. Study Design: This prospective, cross-sectional study screened 324 women with cervical neoplasia for anal neoplasia. Agreement between methods was calculated using the ĸ coefficient. Results: Of 324 anal cytologies performed, 31.5% (n = 102) were found to be abnormal: low-grade anal lesions were detected in 19.1% (n = 62) of cases, high-grade lesions in 3.1% (n = 10) and atypical squamous cells of undetermined significance in 9.3% (n = 30). With respect to the biopsies, 25.7% (n = 20) were positive, consisting of 7 cases of HPV infection, 5 anal intraepithelial neoplasia (AIN) grade 1, 6 AIN grade 2, and 2 AIN grade 3. Twenty-one samples (6.5%) were inadequate for HPV analysis. Of the 303 adequate samples, 84.2% (n = 255) tested positive for HPV. Agreement between cytology and anoscopy was fair (ĸ = 0.31). Agreement between PCR for HPV and cytology was slight (ĸ = 0.08) and no agreement was found between PCR for HPV and anoscopy (ĸ = 0.00). Conclusion: Agreement between the different methods of diagnosing HPV-induced anal lesions is slight to fair; however, anal cytology permits identification of cases in which lesions are present, allowing them to be referred for anoscopy and biopsy.

1.
Holly EA, Ralston ML, Darragh TM, Greenblat RM, Jay N, Palefsky JM: Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93:843–849.
2.
Scholefield JH, Castle MT, Watson NF: Malignant transformation of high-grade anal intraepithelial neoplasia. Brit J Surg 2005;92:1133–1136.
3.
Evans HS, Newnham A, Hodgson SV, Møller H: Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England. Gynecol Oncol 2003;90:131–136.
4.
Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK: Human papillomavirus, smoking and sexual practices in the etiology of anal cancer. Cancer 2004;101:270–280.
5.
Sobhani I, Vuagnat A, Walker F, Vissuzaine C, Mirin B, Hervatin F, Marmuse JP, Crémieux AC, Carbon C, Henin D, Lehy T, Mignon M: Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology 2001;120:857–866.
6.
Fritsch H, Aigner F, Ludwikowski B, Reinstadler-Zankl S, Illig R, Urbas D, Schwarzer C, Longato S: Epithelial and muscular regionalization of the human developing anorectum. Anat Rec 2007;290:1449–1458.
7.
Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S: The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer 1999;85:1139–1144.
8.
Medical Advisory Secretariat: Anal dysplasia screening: evidence bases analyses. Toronto, Ontario, Ministry of Health and Long Term Care, 2007.
9.
Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR: Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer 2004;101:281–288.
10.
Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H: Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006;43:223–233.
11.
Sonnex C, Scholefield J, Kocjan G, Kelly G, Whatrup C, Mindel A, Northover JM: Anal human papillomavirus infection: a comparative study of cytology, colposcopy and DNA hybridization as methods of detection. Genitourin Med 1991;67:21–25.
12.
Moscicki AB, Hills NK, Shiboski S, Darragh TM, Jay N, Powell K, Hanson E, Miller SB, Farhat S, Palefsky J: Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev 1999;8:173–178.
13.
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N; Forum Group Members; Bethesda 2001 Workshop: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114–2119.
14.
Associação Brasileira de Genitoscopia: Nomenclatura para laudos colposcópicos. www.colposcopy.org.br (accessed May 2, 2008).
15.
Kreuter A, Brockmeyer NH, Hochdorfer B, Weissenborn SJ, Stücker M, Swoboda J, Altmeyer P, Pfister H, Wieland U: Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol 2005;52:603–608.
16.
Salvia PN, Bergo SM, Bonesso-Sabadini PI, Tagliarini EB, Hackel C, De Angelo Andrade LA: Correlation between histological criteria and human papillomavirus presence based on PCR assay in cervical biopsies. Int J Gynecol Cancer 2004;14:126–132.
17.
Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159–174.
18.
Colquhoun P, Nogueras JJ, Dipasquale B, Petras R, Wexner SD, Woodhouse S: Interobserver and intraobserver bias exists in the interpretation of anal dysplasia. Dis Colon Rectum 2003;46:1332–1336.
19.
Scholefield JH, Johnson J, Hitchcock A, Kocjan G, Smith JH, Smith PA, Ferryman S, Byass P: Guidelines for anal cytology: to make cytological diagnosis and follow up much more reliable. Cytopathology 1998;9:15–22.
20.
Lytwyn A, Salit IE, Raboud J, Chapman W, Darragh T, Winkler B, Tinmouth J, Mahony JB, Sano M: Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005;103:1447–1456.
21.
Friedlander MA, Stier E, Lin O: Anorectal cytology as a screening tool for anal squamous lesions: cytologic, anoscopic, and histologic correlation. Cancer 2004;102;19–26.
22.
Nathan M, Singh N, Garrett N, Hickey N, Prevost T, Sheaff M: Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings. AIDS 2010;24:373–379.
23.
Nahas CS, da Silva Filho EV, Segurado AA, Genevcius RF, Gerhard R, Gutierrez EB, Marques CF, Cecconello I, Nahas SC: Screening anal dysplasia in HIV-infected patients: is there an agreement between anal pap smear and high-resolution anoscopy-guided biopsy? Dis Colon Rectum 2009;52:1854–1860.
24.
Mathews WC, Sitapati A, Caperna JC, Barber RE, Tugend A, Go U: Measurement characteristics of anal cytology, histopathology, and high-resolution anoscopic visual impression in an anal dysplasia screening program. J Acquir Immune Defic Syndr 2004:37;1610–1615.
25.
Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TM, Burk RD, Strickler HD, Greenblatt RM, Palefsky JM: Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 2009;23:59–70.
26.
Fox PA, Seet JE, Stebbing J, Francis N, Barton SE, Strauss S, Allen-Mersh TG, Gazzard BG, Bower M: The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect 2005;81:142–146.
27.
Damay A, Fabre J, Costes V, Didelot JM, Didelot MN, Boulle N, Segondy M: Human papillomavirus (HPV) prevalence and type distribution, and HPV-associated cytological abnormalities in anal specimens from men infected with HIV who have sex with men. J Med Virol 2010:82:592–596.
28.
Ogilvie JW Jr, Park IU, Downs LS, Anderson KE, Hansberger J, Madoff RD: Anal dysplasia in kidney transplant recipients. J Am Coll Surg 2008;207:914–921.
29.
Vajdic CM, Anderson JS, Hillman RJ, Medley G, Grulich AE: Blind sampling is superior to anoscope guided sampling for screening for anal intraepithelial neoplasia. Sex Transm Infect 2005;81:415–418.
30.
Park IU, Ogilvie JW Jr, Anderson KE, Li ZZ, Darrah L, Madoff R, Downs L Jr: Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia. Gynecol Oncol 2009;114:399–403.
31.
Jay N, Berry M, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM: Colposcopic appearance of anal squamous intraepithelial lesions. Dis Colon Rectum. 1997;40:919–928.
32.
Scholefield JH, Hickson WG, Smith JH, Rogers K, Sharp F: Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet 1992;340:1271–1273.
33.
Giraldo P, Jacyntho C, Costa C, Iglesias M, Gondim C, Carvalho F, Giraldo H, Gonçalves AK: Prevalence of anal squamous intra-epithelial lesion in women presenting genital squamous intra-epithelial lesion. Eur J Obstet Gynecol Reprod Biol 2009;142:73–75.
34.
De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S: Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124:1626–1636.
35.
Hernandez BY, McDuffie K, Zhu X, Wilkens LR, Killeen J, Kessel B, Wakabayashi MT, Bertram CC, Easa D, Ning L, Boyd J, Sunoo C, Kamemoto L, Goodman MT: Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005;14:2550–2556.
36.
Véo CA, Saad SS, Nicolau SM, Melani AG, Denadai MV: Study on the prevalence of human papillomavirus in the anal canal of women with cervical intraepithelial neoplasia grade III. Eur J Obstet Gynecol Reprod Biol 2008;140:103–107.
37.
Mathews C, Caperna J, Cachay ER, Cosman B: Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations. Open AIDS J 2007;1:11–20.
38.
Smith RA, Cokkinides V, Eyre HJ; American Cancer Society: American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 2004;54:41–52.
39.
Clancy CM: Guide to clinical preventive services, 2008. Recommendations of the US Preventive Services Task Force. www.lakesidecommunityhealthcare.com/files/file/PreventiveGuidelines/08 (accessed October 20, 2010).
40.
Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810–819.
41.
Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM: The clinical effectivineses and cost-effectiviness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999;1822–1829.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.